SPAG1 and acute myeloid leukemia: Moreover, ROC analysis revealed that SPAG1 expression may serve as a quantifiable biomarker for distinguishing AML from controls, presenting an AUC of 0.857 (95% CI: 0.783–0.93) (P < 0.001, Fig. 6b).